The objective of this study was to evaluate the frequencies of CYP2C19 mutant alleles (*2, *3, and *17), genotypes, and phenotypes, and the relationship between the frequency of these alleles and the underlying hepatic diseases among patients with advanced liver diseases who were candidates for liver transplantation. The gene discussed is CYP2C19; the disease is liver disorder.